| 5-mC | 5-methylcytosine |
| 6-mA | 6-methlyl-adenine |
| ADMA | asymmetric dimethylarginine |
| AGEs | advanced glycation end products |
| AMHR | anti-Müllerian hormone receptor |
| AP-1 | activator protein 1 |
| AR | androgen receptor |
| ATP | adenosine triphosphate |
| BHMT | betaine homocysteine methyltransferase |
| BMI | body mass index |
| BMP4 | bone morphogenetic protein 4 |
| C3 | complement element 3 |
| CpG | cytosine-phosphate-guanine dinucleotides |
| CRHBP | corticotropin releasing hormone binding protein |
| CRP | C-reactive protein |
| CYP11A1 | cholesterol monooxygenase (cytochrome P450 family 11 subfamily A member 1) |
| CYP17A1 | cytochrome P450 17α-hydroxylase/17,20-lyase |
| CYP19A1 | enzyme aromatase (cytochrome P450 family 19 subfamily A member 1) |
| DAMPs | damage-associated molecular patterns |
| DENND1A | DENN domain containing 1A |
| DENND1A.V2 | DENN domain containing 1A variant 2 |
| DHEA | dehydroepiandrosterone |
| DNA | deoxyribonucleic acid |
| DNMTs | DNA methyltrasferases (e.g., DNMT, DNMT3a, and DNMT3) |
| E | estrogen |
| ER | endoplasmic reticulum |
| ET-1 | endothelin 1 |
| FOXO3A | transcription factor forkhead box protein O3 |
| FSH | follicle-stimulating hormone |
| GCs | granulosa cells |
| GNMT | glycine N-methyltransferase |
| Hcy | homocysteine |
| HDACs | histone deacetylases |
| HMGB-1 | high mobility group box-1 |
| hs-CRP | high-sensitivity C-reactive protein |
| HSD3B2 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 |
| ICAM-1 | Intercellular Adhesion Molecule 1 (CD54) |
| IFN-γ | interferon-gamma |
| IKKβ | I-kappa-B-kinase beta |
| IL | interleukin (e.g.,: IL-6, IL-10, IL-12, IL-18, IL-34) |
| iNOS | inducible nitric oxide synthase |
| IR | insulin resistance |
| IRS | insulin receptor substrate |
| JNK1 | c-Jun N-terminal kinase 1 |
| LH | luteinizing hormone |
| LIF | leukemia inhibitory factor |
| lncRNA | long noncoding RNA |
| MALAT1 | long-chain ncRNA metastasis-related lung adenocarcinoma transcript 1 |
| MAPK14 | mitogen-activated protein kinase 14 (p38α) |
| MCP-1 | monocyte chemoattractant protein-1 |
| MDA | malondialdehyde |
| MDM2 | murine double minute 2 oncogene |
| METTL4 | methyltransferase like 4 |
| MIP-1α | macrophage inflammatory protein-1α |
| miRNA | microRNAs |
| MMP-9 | matrix metalloproteinase-9 |
| MNC | mononuclear cells |
| mtDNA | mitochondrial DNA |
| mtDNMTs | mitochondrial DNA methyltrasferases |
| mTOR | serine-threonine protein kinase mammalian target of rapamycin (mTOR), |
| N6AMT1 | N-6 adenine-specific DNA methyltrasferase 1 |
| NAD+ | nicotinamide adenine dinucleotide |
| NAFLD | nonalcoholic fatty liver disease |
| ncRNAs | noncoding RNAs |
| NF-κB | nuclear factor kappa-light-chain-enhancer of activated B cells |
| NLRP3 | NOD-, LRR- and pyrin domain-containing protein 3 |
| NO | nitric oxide |
| NRF-1 | nuclear respiratory factor 1 |
| OXPHOS | oxidative phosphorylation |
| PAI-I | plasminogen activator inhibitor-I |
| PCOS | polycystic ovary syndrome |
| PGC-1α | peroxisome proliferator activated receptor gamma coactivator-1 alpha |
| PI3K/AKT | phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) signaling pathway |
| PLAC2 | placenta-specific protein 2 |
| PPAR | peroxisome proliferator-activated receptor |
| Prx4 | peroxiredoxin 4 |
| RAGE | cellular membrane receptor for advanced glycation end products |
| Rho/ROCK pathway | Rho/Rho-associated coiled-coil containing protein kinase pathway |
| RNA | ribonucleic acid |
| ROS | reactive oxygen species |
| SIRTs | sirtuins (e.g., SIRT3–sirtuin 3) |
| SIX5 | transcription factor SIX homeobox protein 5 (SIX5) |
| SLE | systemic lupus erythematosus |
| SMAD4 | SMAD family member 4 (mothers against decapentaplegic homolog 4) |
| SOCS | suppressors of cytokine signaling |
| sRAGE | soluble form of receptor for advanced glycation end products |
| STAT | signal transducer and activator of transcription |
| T | testosterone |
| TFAM | mitochondrial transcription factor A p53–protein p53 |
| TGFβ | transforming growth factor β |
| TGFβR1, TGFβR2 | transforming growth factor beta receptor 1 and 2, respectively |
| TLR4 | Toll-like receptor 4 |
| TLR8 | Toll-like receptor 8 |
| TNF-α | tumor necrosis factor alpha |
| TOS | total oxidant status |
| VCAM-1 | vascular cell adhesion protein 1 (CD106) |
| VEGFs | vascular endothelial growth factors |
| WBC | white blood cell count |
| XO | xanthine oxidase |
| YY1 | transcription factor yin-yang 1 |